Toggle navigation
Home
Search
Services
Blog
Contact
About
Gene Therapy for Squamous Cell Cancer
Ledley, Fred D.
Valentis, Inc., Burlingame, CA, United States
Search 16 grants from Fred Ledley
Search grants from Valentis, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Microbial Recognition of Sialic Acid Diversity in the Oral Cavity
Midcareer Investigator Award in Patient-Oriented Research (K24)
Neuro-metabolic coupling in the LGN and visual Cortex
Mechanism for Chemokine Receptor Fusogenic Activity
RNA Synthesis and Transport in Mammalian Cells
Recently added grants:
Signaling pathways that modulate neuronal activity
Parkinsons disease scalable iPSC autologous cell therapy
Blood test to aid treatment decisions for perinatal asphyxiation
Investigating the role of platelets and platelet-derived factors in rejuvenation of the aged hippocampus
Systems Modeling of White Matter Microstructural Abnormalities in Alzheimer's Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AR042111-02
Application #
2081299
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (22))
Project Start
1993-03-26
Project End
1998-05-31
Budget Start
1996-06-15
Budget End
1997-05-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Valentis, Inc.
Department
Type
DUNS #
City
Burlingame
State
CA
Country
United States
Zip Code
94010
Related projects
NIH 1997
R44 AR
Gene Therapy for Squamous Cell Cancer
Ralston, Robert O. / Valentis, Inc.
NIH 1996
R44 AR
Gene Therapy for Squamous Cell Cancer
Ledley, Fred D. / Valentis, Inc.
Comments
Be the first to comment on Fred Ledley's grant